The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 101, 104034
Abstract
No abstract availableKeywords
Funding Information
- Regione Autonoma della Sardegna
- University of Cagliari
This publication has 34 references indexed in Scilit:
- Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen ProbesACS Medicinal Chemistry Letters, 2012
- Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesionsPharmacological Research, 2012
- (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2Nature Chemical Biology, 2011
- Chemistry around imidazopyrazine and ibuprofen: Discovery of novel fatty acid amide hydrolase (FAAH) inhibitorsEuropean Journal of Medicinal Chemistry, 2010
- Effects of COX‐2 inhibition on spinal nociception: the role of endocannabinoidsBritish Journal of Pharmacology, 2010
- R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous CannabinoidsPLOS ONE, 2010
- Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoidsPain, 2010
- Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral NociceptionThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?Physiological Reviews, 2008
- Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacinEuropean Journal of Pharmacology, 2007